Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:19 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 241–264 of 12,116 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Non-interventional. Clear all

Conditions: Postoperative Cognitive Dysfunction, POCD
Interventions: Processed EEG; Procedure
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 65 Years and older
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Tendinopathy
Interventions: Adipose Stem/Stromal Cells for Enthesis/Tendon Therapy (ASSET) Injection; Procedure
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: New York, New York

Conditions: Pulse Oximeter Validation
Interventions: Owlet pulse oximeter neonatal accuracy validation; Device
Lead sponsor: Owlet Baby Care, Inc.; Industry
Eligibility: 0 Days to 28 Days
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Birmingham, Alabama • Minneapolis, Minnesota

Conditions: HIV
Interventions: Multi-component intervention; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years and older
Enrollment: 2,794 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 6
States / cities: Birmingham, Alabama • San Diego, California • Miami, Florida + 3 more

Conditions: Esophagitis, Reflux Esophagitis, Gastroesophageal Reflux Disease
Interventions: Cessation of Acid Suppressing Medications; Other
Lead sponsor: Dallas VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Mild Traumatic Brain Injury
Interventions: Diagnostic test; Device
Lead sponsor: Carey Balaban; Other
Eligibility: 18 Years to 50 Years
Enrollment: 161 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 3
States / cities: San Diego, California • Miami, Florida • Pittsburgh, Pennsylvania

Conditions: Dysphagia
Interventions: swallowing therapy; Behavioral
Lead sponsor: University of Florida; Other
Eligibility: 21 Years to 90 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Chattanooga, Tennessee

Conditions: Social Anxiety Disorder
Interventions: Attention guidance, Control intervention; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 65 Years
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Lung Cancer, Medication Adherence, Symptoms and Signs
Interventions: Conversational Agent/Chatbot, Usual Care; Device · Other
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Tobacco Use Cessation, Tobacco Use, Tobacco Smoking, Tobacco Chewing, Tobacco Dependence
Interventions: Clinic Level: AAC - SDOH, AAC - Tobacco, Non-Bundled, Bundled, Dose 1, Dose 3, Dose 6, Dose 9, Dose 12, RPN, PPN; Behavioral
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 1,560 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Melanoma
Interventions: Non-Interventional; Other
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 18 Years and older
Enrollment: 501 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: High Grade Glioma
Interventions: O-(2-[18F]Fluoroethyl)-L-tyrosine, [18F]-FET with PET/MRI; Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 10 Years to 89 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Stroke
Interventions: Isometric Reaching; Other
Lead sponsor: Shirley Ryan AbilityLab; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Recurrent Tonsillitis, Obstructive Sleep Apnea, Sleep Disordered Breathing, Adverse Reaction to Drug
Interventions: Ibuprofen, Hydrocodone-Acetaminophen; Drug
Lead sponsor: Emory University; Other
Eligibility: 4 Years to 17 Years
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Low Back Pain, Back Pain
Interventions: Sit-stand computer workstation; Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Stanford, California

Conditions: Alzheimers Disease
Interventions: No Intervention; Other
Lead sponsor: Eisai Inc.; Industry
Eligibility: Not listed
Enrollment: 270 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Nutley, New Jersey

Conditions: Childhood Vaccinations
Interventions: Baseline Survey, Pre-intervention Survey, Morally Congruent Message, Morally Non-Congruent Message, Control Message, Post-Intervention Survey; Behavioral
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 850 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Kidney Transplantation, Kidney Disease
Interventions: Alemtuzumab, Sirolimus, Tacrolimus, Kidney transplant, Methylprednisolone (or equivalent), Acetaminophen, Diphenhydramine, Trimethoprim (TMP)/Sulfa (Bactrim, Septra), Valgancyclovir, Acyclovir, Pentamidine, Clotrimazole, Nystatin; Drug · Procedure
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 65 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Peri-implantitis
Interventions: Resective surgery with implantoplasty, Resective surgery with mechanical debridement; Procedure
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years and older
Enrollment: 44 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hypertension
Interventions: Physician-level financial incentives, Practice-level financial incentives, Physician- and practice-level financial incentives; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: Not listed
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2012
U.S. locations: 12
States / cities: Birmingham, Alabama • Newington, Connecticut • Augusta, Georgia + 9 more

Conditions: Schizophrenia, Smoking Cessation, Tobacco Use
Interventions: Active deep transcranial magnetic stimulation (dTMS), Sham dTMS; Device
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 60 Years
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Lung Cancer
Interventions: proteomic profiling, surface-enhanced laser desorption/ionization-time of flight mass spectrometry, biopsy, surgery; Genetic · Other · Procedure
Lead sponsor: Alliance for Clinical Trials in Oncology; Other
Eligibility: 18 Years and older
Enrollment: 1,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 72
States / cities: Birmingham, Alabama • Concord, California • Duarte, California + 53 more

Conditions: Alcohol Drinking, Drinking Behavior, At-risk Drinking, Cardiovascular Risk Factor, High Blood Pressure
Interventions: Alcohol Abstinence, Control arm; Behavioral · Other
Lead sponsor: The University of Texas at Arlington; Other
Eligibility: 26 Years to 49 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Arlington, Texas

Conditions: Multiple Sclerosis, Autoimmune Blistering Disease, B-Cell Deficiency
Interventions: COVID19 vaccine; Biological
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 196 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Search by objective public record fields.

Optimizing Postoperative Cognition the Elderly

Autologous Fat Grafting for the Treatment of Chronic Tendinopathy

Evaluation of Accuracy of the Owlet OSS 3.0 Sensor in the Neonatal Population

HIV Clinic-Based Intervention to Improve ART Adherence and Prevent HIV Transmission

The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis

Standardized Instruments to Provide Diagnostic and Prognostic Information in Mild Traumatic Brain Injury (mTBI)

Adjunctive Neuromuscular Electrical Stimulation for the Rehabilitation of Swallowing

Efficacy of an Attention Guidance VR Intervention for Social Anxiety Disorder

Implementation Strategies for Monitoring Adherence in Real Time

Reach Through Equitable Implementation in Utah

A Study is to Understand the Treatment Patterns for Immunotherapy Agents and BRAF/MEK Inhibitors Used in the Treatment of Advanced Melanoma

Multiparametic Metabolic and Hypoxic PET/MRI for Disease Assessment in High Grade Glioma

R01.Aim 2.Study 1: IsoReach

Post-operative Pain Control After Pediatric Adenotonsillectomy

Access to a Sit-stand Computer Workstation and Back Pain

A Postmarketing Study of LEQEMBI in Participants With Alzheimer's Disease

Tailoring of Vaccine-Focused Messages: Moral Foundations

Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

Peri-implantitis Management: Surgical and Maintenance Outcomes

Financial Incentives to Translate ALLHAT Into Practice: A Randomized Trial

Deep rTMS Modulating Insula Synaptic Density and Smoking Behavior in Schizophrenia

Proteomic Profiling in Diagnosing Non-Small Cell Lung Cancer in Patients Who Are Undergoing Lung Resection for Suspicious Stage I Lung Lesions

Reducing Cardiovascular Risks: The Role of Alcohol Use

Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients